PubMed COVID-19 Clinical Care
4811 - 4820 of 5506 results found
Collagenous colitis incomplete triggered by SARS-CoV-2 infection
Description
No abstract
Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine
Description
A woman in her mid-twenties was admitted with headache, ultimately leading to a diagnosis of cerebral venous sinus thrombosis 10 days after receiving a first dose of the AstraZeneca ChAdOx1 nCoV-19 vaccine (Vaxzevria). We report this case from
COVID-19 Vaccine-Associated Pneumonitis in the Republic of Korea: A Nationwide Multicenter Survey
Description
CONCLUSION: These results suggest pneumonitis as a potentially significant safety concern for vaccines against SARS-CoV-2. Clinical awareness and patient education are necessary for early recognition and prompt management. Additional research is
COVID-19: Shehecheyanu
Description
No abstract
COVID-19 update: Pfizer bivalent vaccine booster dose for children 6 months to 4 years old
Description
No abstract
Circulation of a digital community currency
Description
Circulation is the characteristic feature of successful currency systems, from community currencies to cryptocurrencies to national currencies. In this paper, we propose a network analysis approach especially suited for studying circulation given a
Comparison of thromboembolic risk scores for evaluating in-hospital events of COVID-19 patients
Description
Aim: To compare the effectiveness of thromboembolic risk scores in determining in-hospital events of COVID-19 patients. Methods: This retrospective study included a total of 410 consecutive COVID-19 patients. Scores including CHA(2)DS(2)-VASc-HS
Covid-19-ARDS hat bei über 80-Jährigen eine höhere Sterblichkeit als non-Covid-ARDS
Description
No abstract
COVID-19 vaccine hesitancy among pregnant and postpartum Kenyan women
Description
CONCLUSIONS: Our findings suggest that sustaining access to quality MCH services may decrease COVID-19 vaccine hesitancy. Willingness to receive the vaccine doubled over the 2-year period in our cohort, suggesting increased trust for use and
